PMID: 26807201Jan 26, 2016Paper

Tumor cell expression of MMP3 as a prognostic factor for poor survival in pancreatic, pulmonary, and mammary carcinoma

Genes & Cancer
Christine MehnerDerek C Radisky

Abstract

Breast, lung, and pancreatic cancers collectively represent one third of all diagnosed tumors and are responsible for almost 40% of overall cancer mortality. Despite improvements in current treatments, efforts to develop more specific therapeutic options are warranted. Here we identify matrix metalloproteinase 3 (MMP3) as a potential target within all three of these tumor types. MMP3 has previously been shown to induce expression of Rac1b, a tumorigenic splice isoform of Rac1. In this study we find that MMP3 and Rac1b proteins are both strongly expressed by the tumor cells of all three tumor types and that expression of MMP3 protein is prognostic of poor survival in pancreatic cancer patients. We also find that MMP3 gene expression can serve as a prognostic marker for patient survival in breast and lung cancer. These results suggest an oncogenic MMP3-Rac1b signaling axis as a driver of tumor progression in three common poor prognosis tumor types, further suggesting that new therapies to target these pathways could have substantial therapeutic benefit.

References

Nov 10, 2001·Science·I R Vetter, A Wittinghofer
Mar 30, 2002·Science·Lisa M CoussensLynn M Matrisian
May 7, 2002·Nature Reviews. Cancer·Mikala Egeblad, Zena Werb
Aug 30, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M J MooreUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Nov 20, 2003·The Journal of Biological Chemistry·Dennis FiegenMohammad R Ahmadian
Feb 1, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Donald BissettFrances A Shepherd
Dec 27, 2005·Current Opinion in Genetics & Development·Derek C Radisky, Mina J Bissell
Mar 16, 2006·British Journal of Cancer·C M Overall, O Kleifeld
Mar 23, 2006·The Journal of Biological Chemistry·Paulo Matos, Peter Jordan
Apr 12, 2006·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Mary T GalganoHenry F Frierson
Jan 11, 2007·Journal of Cellular Biochemistry·Derek C RadiskyMina J Bissell
Mar 8, 2007·British Journal of Cancer·F J VizosoJ L García-Muñiz
Apr 21, 2007·Reviews in Endocrine & Metabolic Disorders·Evette S Radisky, Derek C Radisky
Jun 26, 2007·Cells, Tissues, Organs·Melody Stallings-Mann, Derek Radisky
Oct 13, 2007·The Journal of Biological Chemistry·Adam ShutesChanning J Der
Apr 1, 2008·Methods in Enzymology·Cercina OnestoChanning J Der
Jul 23, 2008·Molecular Cancer Research : MCR·Paulo Matos, Peter Jordan
Jun 3, 2009·Molecular and Cellular Biology·Patrícia BarrosPaulo Matos
Apr 17, 2010·The Journal of Biological Chemistry·Lidiya OrlichenkoDerek C Radisky
May 5, 2010·Journal of Mammary Gland Biology and Neoplasia·Evette S Radisky, Derek C Radisky
Jun 1, 2010·Best Practice & Research. Clinical Gastroenterology·Sara RaimondiRaffaele Pezzilli
Feb 10, 2011·CA: a Cancer Journal for Clinicians·Suresh S RamalingamFadlo R Khuri
May 31, 2011·Lancet·Audrey VincentMichael Goggins
Aug 30, 2011·The American Journal of Pathology·Cory M YamashitaGregory P Downey
Feb 22, 2012·Journal of Cellular Biochemistry·Federico PelischAnabella Srebrow
Apr 17, 2012·Trends in Pharmacological Sciences·Harry JubbTom L Blundell
May 16, 2012·Cancer Discovery·Edward S KimWaun K Hong
Jul 13, 2012·Science Translational Medicine·Sandra S McAllister
Jul 13, 2012·Science Translational Medicine·Melody L Stallings-MannDerek C Radisky
Jan 30, 2013·Neoplasia : an International Journal for Oncology Research·Paulo MatosPeter Jordan

❮ Previous
Next ❯

Citations

Aug 29, 2020·Cancers·Siobhan SimpsonCatrin S Rutland
Apr 21, 2018·Scientific Reports·Stephanie E A BurnellShareen H Doak
Jun 27, 2019·World Journal of Gastrointestinal Oncology·Hmc Shantha KumaraRichard L Whelan
Oct 6, 2020·Frontiers in Oncology·Evelyn Sirait-FischerAndreas Weigert
Sep 29, 2018·Cancers·Laurie G HudsonAngela Wandinger-Ness
Mar 12, 2020·Journal of Enzyme Inhibition and Medicinal Chemistry·Alisha T PooleVincent C Chen
Jun 18, 2019·Future Science OA·Aldo PezzutoGiuseppe Tonini
Apr 12, 2017·Molecular Cancer Research : MCR·Sorah YoonJohn J Rossi
Aug 31, 2019·Oncogene·Sourik S GangulyCindy K Miranti
Mar 7, 2020·Journal of breast cancer·Shafinah Ahmad SuhaimiRozita Rosli
Mar 18, 2020·Cancers·Larissa Kotelevets, Eric Chastre
Feb 6, 2017·Journal of Controlled Release : Official Journal of the Controlled Release Society·Kyle J IsaacsonHamidreza Ghandehari
Apr 4, 2021·Cancers·Zoi PiperigkouNikos K Karamanos
Nov 20, 2016·International Journal of Pharmaceutics·Larissa KotelevetsPatrick Couvreur
Jun 22, 2021·Frontiers in Genetics·Sergey NikulinAlexander Tonevitsky
Aug 21, 2021·Frontiers in Veterinary Science·Catrin S RutlandNigel P Mongan
Aug 20, 2021·Mechanisms of Ageing and Development·Tanya PulidoFatouma Alimirah
Aug 28, 2021·International Journal of Molecular Sciences·Angela Ximena Argote CamachoMaría Isabel Núñez
Aug 31, 2021·World Journal of Gastrointestinal Oncology·Hmc Shantha KumaraRichard L Whelan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.